GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Solventum Corp (FRA:KB7) » Definitions » DeferredTaxAndRevenue

Solventum (FRA:KB7) DeferredTaxAndRevenue : €516 Mil (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Solventum DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Solventum's current deferred tax and revenue for the quarter that ended in Mar. 2025 was €516 Mil.

Solventum DeferredTaxAndRevenue Historical Data

The historical data trend for Solventum's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solventum DeferredTaxAndRevenue Chart

Solventum Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
DeferredTaxAndRevenue
- 507.99 527.70 526.36 546.26

Solventum Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 520.72 469.15 507.26 546.26 516.15

Solventum DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Solventum's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Solventum Business Description

Traded in Other Exchanges
Address
2510 Conway Avenue East, 3M Center, Building 275-6W, Maplewood, MN, USA, 55144
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.

Solventum Headlines

No Headlines